The nucleocapsid protein of coronaviruses acts as a viral suppressor of RNA silencing in mammalian cells

Journal of Virology

Volumn 89, Issue 17, 2015, Pages 9029-9043

  Cui, Lei ^a   Wang, Haiying ^a   Ji, Yanxi ^a   Yang, Jie ^a   Xu, Shan ^a   Huang, Xingyu ^a   Wang, Zidao ^a   Qin, Lei ^a   Tien, Po ^a   Zhou, Xi ^a   Guo, Deyin ^a   Chen, Yu ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGONAUTE 2 PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; NUCLEOCAPSID PROTEIN; RNA; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; ARGONAUTE PROTEIN; DEAD BOX PROTEIN; DICER1 PROTEIN, MOUSE; EIF2C2 PROTEIN, MOUSE; NUCLEOCAPSID PROTEIN, CORONAVIRUS; RIBONUCLEASE III;

AGO2 GENE; ANIMAL CELL; ARTICLE; CELL CULTURE; CELLULAR IMMUNITY; CONTROLLED STUDY; CORONAVIRIDAE; DICER1 GENE; GENE; GENE SEQUENCE; GENE SILENCING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA CLEAVAGE; RNA INTERFERENCE; VIRUS CELL INTERACTION; VIRUS REPLICATION; AMINO ACID SEQUENCE; ANIMAL; BIOSYNTHESIS; CELL LINE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEK293 CELL LINE; IMMUNOLOGY; L CELL LINE; MURINE HEPATITIS VIRUS; NUCLEOTIDE SEQUENCE; SEQUENCE ALIGNMENT; SEVERE ACUTE RESPIRATORY SYNDROME; VIROLOGY;

CORONAVIRIDAE; CORONAVIRUS; EUKARYOTA; HEXAPODA; MAMMALIA; MURINE HEPATITIS VIRUS; NEMATODA; SARS CORONAVIRUS;

AMINO ACID SEQUENCE; ANIMALS; ARGONAUTE PROTEINS; BASE SEQUENCE; CELL LINE; CORONAVIRUS; DEAD-BOX RNA HELICASES; HEK293 CELLS; HUMANS; L CELLS (CELL LINE); MICE; MURINE HEPATITIS VIRUS; NUCLEOCAPSID PROTEINS; RIBONUCLEASE III; RNA INTERFERENCE; RNA, SMALL INTERFERING; SEQUENCE ALIGNMENT; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 84938916581     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01331-15     Document Type: Article

References (74)

1. Carthew RW, Sontheimer EJ. 2009. Origins and mechanisms of miRNAs and siRNAs. Cell 136:642-655. http://dx.doi.org/10.1016/j.cell.2009.01.035.
2. Ding SW. 2010. RNA-based antiviral immunity. Nat Rev Immunol 10: 632-644. http://dx.doi.org/10.1038/nri2824.
3. Umbach JL, Cullen BR. 2009. The role of RNAi and microRNAs in animal virus replication and antiviral immunity. Genes Dev 23:1151-1164. http://dx.doi.org/10.1101/gad.1793309.
4. Takeuchi O, Akira S. 2009. Innate immunity to virus infection. Immunol Rev 227:75-86. http://dx.doi.org/10.1111/j.1600-065X.2008.00737.x.
5. Parameswaran P, Sklan E, Wilkins C, Burgon T, Samuel MA, Lu R, Ansel KM, Heissmeyer V, Einav S, Jackson W, Doukas T, Paranjape S, Polacek C, FB dos Santos, Jalili R, Babrzadeh F, Gharizadeh B, Grimm D, Kay M, Koike S, Sarnow P, Ronaghi M, Ding SW, Harris E, Chow M, Diamond MS, Kirkegaard K, Glenn JS, Fire AZ. 2010. Six RNA viruses and forty-one hosts: viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems. PLoS Pathog 6:e1000764. http://dx.doi.org/10.1371/journal.ppat.1000764.
6. Li Y, Lu J, Han Y, Fan X, Ding SW. 2013. RNA interference functions as an antiviral immunity mechanism in mammals. Science 342:231-234. http://dx.doi.org/10.1126/science.1241911.
7. Maillard PV, Ciaudo C, Marchais A, Li Y, Jay F, Ding SW, Voinnet O. 2013. Antiviral RNA interference in mammalian cells. Science 342:235-238. http://dx.doi.org/10.1126/science.1241930.
8. Sagan SM, Sarnow P. 2013. Molecular biology: RNAi, antiviral after all. Science 342:207-208. http://dx.doi.org/10.1126/science.1245475.
9. Voinnet O. 2005. Induction and suppression of RNA silencing: insights from viral infections. Nat Rev Genet 6:206-220. http://dx.doi.org/10.1038/nrg1555.
10. Bivalkar-Mehla S, Vakharia J, Mehla R, Abreha M, Kanwar JR, Tikoo A, Chauhan A. 2011. Viral RNA silencing suppressors (RSS): novel strategy of viruses to ablate the host RNA interference (RNAi) defense system. Virus Res 155:1-9. http://dx.doi.org/10.1016/j.virusres.2010.10.003.
11. Hemmes H, Lakatos L, Goldbach R, Burgyan J, Prins M. 2007. The NS3 protein of Rice hoja blanca tenuivirus suppresses RNA silencing in plant and insect hosts by efficiently binding both siRNAs and miRNAs. RNA 13:1079-1089. http://dx.doi.org/10.1261/rna.444007.
12. Gonzalez I, Martinez L, Rakitina DV, Lewsey MG, Atencio FA, Llave C, Kalinina NO, Carr JP, Palukaitis P, Canto T. 2010. Cucumber mosaic virus 2b protein subcellular targets and interactions: their significance to RNA silencing suppressor activity. Mol Plant-Microbe Interact 23:294-303. http://dx.doi.org/10.1094/MPMI-23-3-0294.
13. Lakatos L, Szittya G, Silhavy D, Burgyan J. 2004. Molecular mechanism of RNA silencing suppression mediated by p19 protein of tombusviruses. EMBO J 23:876-884. http://dx.doi.org/10.1038/sj.emboj.7600096.
14. Haas G, Azevedo J, Moissiard G, Geldreich A, Himber C, Bureau M, Fukuhara T, Keller M, Voinnet O. 2008. Nuclear import of CaMV P6 is required for infection and suppression of the RNA silencing factor DRB4. EMBO J 27:2102-2112. http://dx.doi.org/10.1038/emboj.2008.129.
15. Thomas CL, Leh V, Lederer C, Maule AJ. 2003. Turnip crinkle virus coat protein mediates suppression of RNA silencing in Nicotiana benthamiana. Virology 306:33-41. http://dx.doi.org/10.1016/S0042-6822(02)00018-1.
16. Chao JA, Lee JH, Chapados BR, Debler EW, Schneemann A, Williamson JR. 2005. Dual modes of RNA-silencing suppression by Flock House virus protein B2. Nat Struct Mol Biol 12:952-957. http://dx.doi.org/10.1038/nsmb1005.
17. Li H, Li WX, Ding SW. 2002. Induction and suppression of RNA silencing by an animal virus. Science 296:1319-1321. http://dx.doi.org/10.1126/science.1070948.
18. Qi N, Zhang L, Qiu Y, Wang Z, Si J, Liu Y, Xiang X, Xie J, Qin CF, Zhou X, Hu Y. 2012. Targeting of dicer-2 and RNA by a viral RNA silencing suppressor in Drosophila cells. J Virol 86:5763-5773. http://dx.doi.org/10.1128/JVI.07229-11.
19. Qi N, Cai D, Qiu Y, Xie J, Wang Z, Si J, Zhang J, Zhou X, Hu Y. 2011. RNA binding by a novel helical fold of b2 protein from Wuhan nodavirus mediates the suppression of RNA interference and promotes b2 dimerization. J Virol 85:9543-9554. http://dx.doi.org/10.1128/JVI.00785-11.
20. Haasnoot J, de Vries W, Geutjes EJ, Prins M, de Haan P, Berkhout B. 2007. The Ebola virus VP35 protein is a suppressor ofRNAsilencing. PLoS Pathog 3:e86. http://dx.doi.org/10.1371/journal.ppat.0030086.
21. Bucher E, Hemmes H, de Haan P, Goldbach R, Prins M. 2004. The influenza A virus NS1 protein binds small interfering RNAs and suppresses RNA silencing in plants. J Gen Virol 85:983-991. http://dx.doi.org/10.1099/vir.0.19734-0.
22. Li WX, Li H, Lu R, Li F, Dus M, Atkinson P, Brydon EW, Johnson KL, Garcia-Sastre A, Ball LA, Palese P, Ding SW. 2004. Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing. Proc Natl Acad Sci U S A 101:1350-1355. http://dx.doi.org/10.1073/pnas.0308308100.
23. Sullivan CS, Ganem D. 2005. A virus-encoded inhibitor that blocks RNA interference in mammalian cells. J Virol 79:7371-7379. http://dx.doi.org/10.1128/JVI.79.12.7371-7379.2005.
24. Bennasser Y, Le SY, Benkirane M, Jeang KT. 2005. Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 22:607-619. http://dx.doi.org/10.1016/j.immuni.2005.03.010.
25. Chen W, Zhang Z, Chen J, Zhang J, Zhang J, Wu Y, Huang Y, Cai X, Huang A. 2008. HCV core protein interacts with Dicer to antagonize RNA silencing. Virus Res 133:250-258. http://dx.doi.org/10.1016/j.virusres.2008.01.011.
26. Basler CF, Wang X, Muhlberger E, Volchkov V, Paragas J, Klenk HD, Garcia-Sastre A, Palese P. 2000. The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci U S A 97:12289-12294. http://dx.doi.org/10.1073/pnas.220398297.
27. Brand SR, Kobayashi R, Mathews MB. 1997. The Tat protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-induced, virally activated protein kinase, PKR. J Biol Chem 272:8388-8395. http://dx.doi.org/10.1074/jbc.272.13.8388.
28. Geiss GK, Salvatore M, Tumpey TM, Carter VS, Wang X, Basler CF, Taubenberger JK, Bumgarner RE, Palese P, Katze MG, Garcia-Sastre A. 2002. Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc Natl Acad SciUSA99:10736-10741. http://dx.doi.org/10.1073/pnas.112338099.
29. Perlman S, Netland J. 2009. Coronaviruses post-SARS: update on repli-cation and pathogenesis. Nat Rev Microbiol 7:439-450. http://dx.doi.org/10.1038/nrmicro2147.
30. Knoops K, Kikkert M, Worm SH, Zevenhoven-Dobbe JC, van der Meer Y, Koster AJ, Mommaas AM, Snijder EJ. 2008. SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum. PLoS Biol 6:e226. http://dx.doi.org/10.1371/journal.pbio.0060226.
31. Weber F, Wagner V, Rasmussen SB, Hartmann R, Paludan SR. 2006. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J Virol 80:5059-5064. http://dx.doi.org/10.1128/JVI.80.10.5059-5064.2006.
32. Karjee S, Minhas A, Sood V, Ponia SS, Banerjea AC, Chow VT, Mukherjee SK, Lal SK. 2010. The 7a accessory protein of severe acute respiratory syndrome coronavirus acts as an RNA silencing suppressor. J Virol 84:10395-10401. http://dx.doi.org/10.1128/JVI.00748-10.
33. Yount B, Roberts RS, Sims AC, Deming D, Frieman MB, Sparks J, Denison MR, Davis N, Baric RS. 2005. Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice. J Virol 79:14909-14922. http://dx.doi.org/10.1128/JVI.79.23.14909-14922.2005.
34. Tan YJ, Lim SG, Hong W. 2006. Understanding the accessory viral proteins unique to the severe acute respiratory syndrome (SARS) coronavirus. Antivir Res 72:78-88. http://dx.doi.org/10.1016/j.antiviral.2006.05.010.
35. Tang TK, Wu MP, Chen ST, Hou MH, Hong MH, Pan FM, Yu HM, Chen JH, Yao CW, Wang AH. 2005. Biochemical and immunological studies of nucleocapsid proteins of severe acute respiratory syndrome and 229E human coronaviruses. Proteomics 5:925-937. http://dx.doi.org/10.1002/pmic.200401204.
36. Takeda M, Chang CK, Ikeya T, Guntert P, Chang YH, Hsu YL, Huang TH, Kainosho M. 2008. Solution structure of the c-terminal dimerization domain of SARS coronavirus nucleocapsid protein solved by the SAILNMR method. J Mol Biol 380:608-622. http://dx.doi.org/10.1016/j.jmb.2007.11.093.
37. Baric RS, Nelson GW, Fleming JO, Deans RJ, Keck JG, Casteel N, Stohlman SA. 1988. Interactions between coronavirus nucleocapsid protein and viral RNAs: implications for viral transcription. J Virol 62:4280-4287.
38. Grossoehme NE, Li L, Keane SC, Liu P, Dann CE, III, Leibowitz JL, Giedroc DP. 2009. Coronavirus N protein N-terminal domain (NTD) specifically binds the transcriptional regulatory sequence (TRS) and melts TRS-cTRS RNA duplexes. J Mol Biol 394:544-557. http://dx.doi.org/10.1016/j.jmb.2009.09.040.
39. Tylor S, Andonov A, Cutts T, Cao JX, Grudesky E, Van Domselaar G, Li XG, He RT. 2009. The SR-rich motif in SARS-CoV nucleocapsid protein is important for virus replication. Can J Microbiol 55:254-260. http://dx.doi.org/10.1139/W08-139.
40. Almazan F, Galan C, Enjuanes L. 2004. The nucleoprotein is required for efficient coronavirus genome replication. J Virol 78:12683-12688. http://dx.doi.org/10.1128/JVI.78.22.12683-12688.2004.
41. Lu X, Pan J, Tao J, Guo D. 2011. SARS-CoV nucleocapsid protein antagonizes IFN-beta response by targeting initial step of IFN-beta induction pathway, and its C-terminal region is critical for the antagonism. Virus Genes 42:37-45. http://dx.doi.org/10.1007/s11262-010-0544-x.
42. Chang CK, Sue SC, Yu TH, Hsieh CM, Tsai CK, Chiang YC, Lee SJ, Hsiao HH, Wu WJ, Chang WL, Lin CH, Huang TH. 2006. Modular organization of SARS coronavirus nucleocapsid protein. J Biomed Sci 13: 59-72. http://dx.doi.org/10.1007/s11373-005-9035-9.
43. Huang Q, Yu L, Petros AM, Gunasekera A, Liu Z, Xu N, Hajduk P, Mack J, Fesik SW, Olejniczak ET. 2004. Structure of the N-terminal RNA-binding domain of the SARS CoV nucleocapsid protein. Biochemistry 43:6059-6063. http://dx.doi.org/10.1021/bi036155b.
44. Luo H, Ye F, Chen K, Shen X, Jiang H. 2005. SR-rich motif plays a pivotal role in recombinant SARS coronavirus nucleocapsid protein multimerization. Biochemistry 44:15351-15358. http://dx.doi.org/10.1021/bi051122c.
45. Luo H, Chen J, Chen K, Shen X, Jiang H. 2006. Carboxyl terminus of severe acute respiratory syndrome coronavirus nucleocapsid protein: selfassociation analysis and nucleic acid binding characterization. Biochemistry 45:11827-11835. http://dx.doi.org/10.1021/bi0609319.
46. Chen CY, Chang CK, Chang YW, Sue SC, Bai HI, Riang L, Hsiao CD, Huang TH. 2007. Structure of the SARS coronavirus nucleocapsid protein RNA-binding dimerization domain suggests a mechanism for helical packaging of viral RNA. J Mol Biol 368:1075-1086. http://dx.doi.org/10.1016/j.jmb.2007.02.069.
47. Liu D, Wu A, Cui L, Hao R, Wang Y, He J, Guo D. 2014. Hepatitis B virus polymerase suppresses NF-κB signaling by inhibiting the activity of IKKs via interaction with Hsp90β. PLoS One 9:e91658. http://dx.doi.org/10.1371/journal.pone.0091658.
48. Chang GH, Luo BJ, Lu P, Lin L, Wu XY, Li J, Hu Y, Zhu QY. 2011. Construction and genetic analysis of murine hepatitis virus strain A59 Nsp16 temperature-sensitive mutant and the revertant virus. Virol Sin 26:19-29. http://dx.doi.org/10.1007/s12250-011-3145-x.
49. Chen Y, Su C, Ke M, Jin X, Xu L, Zhang Z, Wu A, Sun Y, Yang Z, Tien P, Ahola T, Liang Y, Liu X, Guo D. 2011. Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2=-Omethylation by nsp16/nsp10 protein complex. PLoS Pathog 7:e1002294. http://dx.doi.org/10.1371/journal.ppat.1002294.
50. Kopecky-Bromberg SA, Martinez-Sobrido L, Frieman M, Baric RA, Palese P. 2007. Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J Virol 81:548-557. http://dx.doi.org/10.1128/JVI.01782-06.
51. Ji X. 2008. The mechanism of RNase III action: how dicer dices. Curr Top Microbiol Immunol 320:99-116.
52. Lingel A, Simon B, Izaurralde E, Sattler M. 2005. The structure of the flock house virus B2 protein, a viral suppressor of RNA interference, shows a novel mode of double-stranded RNA recognition. EMBO Rep 6:1149-1155. http://dx.doi.org/10.1038/sj.embor.7400583.
53. Chang CK, Hsu YL, Chang YH, Chao FA, Wu MC, Huang YS, Hu CK, Huang TH. 2009. Multiple Nucleic acid binding sites and intrinsic disorder of severe acute respiratory syndrome coronavirus nucleocapsid protein: implications for ribonucleocapsid protein packaging. J Virol 83: 2255-2264. http://dx.doi.org/10.1128/JVI.02001-08.
54. McBride R, van Zyl M, Fielding BC. 2014. The coronavirus nucleocapsid is a multifunctional protein. Viruses 6:2991-3018. http://dx.doi.org/10.3390/v6082991.
55. Pan J, Peng X, Gao Y, Li Z, Lu X, Chen Y, Ishaq M, Liu D, Dediego ML, Enjuanes L, Guo D. 2008. Genome-wide analysis of protein-protein interactions and involvement of viral proteins in SARS-CoV replication. PLoS One 3:e3299. http://dx.doi.org/10.1371/journal.pone.0003299.
56. Ye Y, Hauns K, Langland JO, Jacobs BL, Hogue BG. 2007. Mouse hepatitis coronavirus A59 nucleocapsid protein is a type I interferon antagonist. J Virol 81:2554-2563. http://dx.doi.org/10.1128/JVI.01634-06.
57. Roth-Cross JK, Bender SJ, Weiss SR. 2008. Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microglia. J Virol 82:9829-9838. http://dx.doi.org/10.1128/JVI.01199-08.
58. Roth-Cross JK, Martinez-Sobrido L, Scott EP, Garcia-Sastre A, Weiss SR. 2007. Inhibition of the alpha/beta interferon response by mouse hepatitis virus at multiple levels. J Virol 81:7189-7199. http://dx.doi.org/10.1128/JVI.00013-07.
59. Rose KM, Weiss SR. 2009. Murine coronavirus cell type dependent interaction with the type I interferon response. Viruses 1:689-712. http://dx.doi.org/10.3390/v1030689.
60. Zhou H, Perlman S. 2007. Mouse hepatitis virus does not induce beta interferon synthesis and does not inhibit its induction by double-stranded RNA. J Virol 81:568-574. http://dx.doi.org/10.1128/JVI.01512-06.
61. Versteeg GA, Bredenbeek PJ, van den Worm SH, Spaan WJ. 2007. Group 2 coronaviruses prevent immediate-early interferon induction by protection of viral RNA from host cell recognition. Virology 361:18-26. http://dx.doi.org/10.1016/j.virol.2007.01.020.
62. Gosert R, Kanjanahaluethai A, Egger D, Bienz K, Baker SC. 2002. RNA replication of mouse hepatitis virus takes place at double-membrane vesicles. J Virol 76:3697-3708. http://dx.doi.org/10.1128/JVI.76.8.3697-3708.2002.
63. Snijder EJ, van der Meer Y, Zevenhoven-Dobbe J, Onderwater JJ, van der Meulen J, Koerten HK, Mommaas AM. 2006. Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex. J Virol 80:5927-5940. http://dx.doi.org/10.1128/JVI.02501-05.
64. Chen Y, Cai H, Pan J, Xiang N, Tien P, Ahola T, Guo D. 2009. Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase. Proc Natl Acad Sci U S A 106:3484-3489. http://dx.doi.org/10.1073/pnas.0808790106.
65. de Haan CA, Rottier PJ. 2005. Molecular interactions in the assembly of coronaviruses. Adv Virus Res 64:165-230.
66. Masters PS. 2006. The molecular biology of coronaviruses. Adv Virus Res 66:193-292.
67. Niemeyer D, Zillinger T, Muth D, Zielecki F, Horvath G, Suliman T, Barchet W, Weber F, Drosten C, Muller MA. 2013. Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist. J Virol 87:12489-12495. http://dx.doi.org/10.1128/JVI.01845-13.
68. Hsieh PK, Chang SC, Huang CC, Lee TT, Hsiao CW, Kou YH, Chen IY, Chang CK, Huang TH, Chang MF. 2005. Assembly of severe acute respiratory syndrome coronavirus RNA packaging signal into virus-like particles is nucleocapsid dependent. J Virol 79:13848-13855. http://dx.doi.org/10.1128/JVI.79.22.13848-13855.2005.
69. Masters PS. 1992. Localization of an RNA-binding domain in the nucleocapsid protein of the coronavirus mouse hepatitis virus. Arch Virol 125: 141-160. http://dx.doi.org/10.1007/BF01309634.
70. Hurst KR, Koetzner CA, Masters PS. 2013. Characterization of a critical interaction between the coronavirus nucleocapsid protein and nonstructural protein 3 of the viral replicase-transcriptase complex. J Virol 87: 9159-9172. http://dx.doi.org/10.1128/JVI.01275-13.
71. Kuo L, Koetzner CA, Hurst KR, Masters PS. 2014. Recognition of the murine coronavirus genomic RNA packaging signal depends on the second RNA-binding domain of the nucleocapsid protein. J Virol 88:4451-4465. http://dx.doi.org/10.1128/JVI.03866-13.
72. Cervantes-Barragan L, Zust R, Weber F, Spiegel M, Lang KS, Akira S, Thiel V, Ludewig B. 2007. Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. Blood 109:1131-1137.
73. Cervantes-Barragan L, Kalinke U, Zust R, Konig M, Reizis B, Lopez-Macias C, Thiel V, Ludewig B. 2009. Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection. J Immunol 182:1099-1106. http://dx.doi.org/10.4049/jimmunol.182.2.1099.
74. Schelle B, Karl N, Ludewig B, Siddell SG, Thiel V. 2005. Selective replication of coronavirus genomes that express nucleocapsid protein. J Virol 79:6620-6630. http://dx.doi.org/10.1128/JVI.79.11.6620-6630.2005.